文献速递气道管理

耳鼻喉手术中流量控制通气的前瞻性观察研究

Flow-controlled ventilation during ear, nose and throat surgery: A prospective observational study.
PubMed 文献 · Eur J Anaesthesiol · 2019-01-01

结果显示分钟通气量5.0 [4.4-6.4] L/min、呼吸频率9 [8-11]次/分时,呼气末CO2为4.9 [4.8-5.0] kPa,潮内气管压幅Δp为10 [9-12] cmH2O。记录到5例不良事件:1例分泌物致导管阻塞,4例导管移位(2例归因于咳嗽,2例与研究无关)。结论认为FCV可达到合适PetCO2,但窄导管高阻力可能增加咳嗽时导管移位风险。

要点

  • FCV在耳鼻喉手术中可维持正常范围内PetCO2和Δp
  • 窄口径Tritube导管高流阻可能增加咳嗽时导管移位风险
  • FCV为短期机械通气和气道管理提供新选择

核心结论

  • FCV在耳鼻喉手术患者中可达到合适PetCO2水平,分钟通气量和Δp在正常范围。
  • Tritube高流阻可能增加患者咳嗽时导管移位的可能性。
  • FCV为短期机械通气提供新选择,窄导管成功运行有助于气道管理。

研究设计与样本

  • 前瞻性观察性研究,2017年11月24日至2018年1月9日在两家德国学术医疗中心进行。
  • 排除标准包括计划激光手术、计划纤维支气管镜清醒插管、急诊手术、误吸风险增加、ASA分级>III级及COPD GOLD分期>II级。

主要发现

  • 分钟通气量5.0 [4.4-6.4] L/min、呼吸频率9 [8-11]次/分时,PetCO2为4.9 [4.8-5.0] kPa。
  • 潮内气管压幅Δp为10 [9-12] cmH2O。
  • 记录5例不良事件:1例气道分泌物致导管阻塞,4例导管移位(2例归因于咳嗽,2例与研究无关)。

关键数值与推荐

  • 每5分钟记录分钟通气量、呼吸频率、潮内气管压幅Δp和呼气末CO2。
  • 数据以中位数[IQR]表示。

临床怎么用

  • FCV可考虑用于耳鼻喉手术短期机械通气,需注意窄导管高流阻相关的导管移位风险。
  • 使用期间应监测气道分泌物和咳嗽情况,警惕导管阻塞和移位。

局限性

  • 样本量小,仅15组可评估数据。
  • 为观察性研究,非对照设计。
  • 作者指出需进一步评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Flow-controlled ventilation (FCV) is a new mechanical ventilation mode that maintains constant flow during inspiration and expiration with standard tidal volumes via cuffed narrow-bore endotracheal tubes. Originating in manually operated 'expiratory ventilation assistance', FCV extends this technique by automatic control of airway flow, monitoring of intratracheal pressure and control of peak inspiratory pressure and end-expiratory pressure. FCV has not yet been described in a clinical study. OBJECTIVE: The aim of this study was to provide an initial assessment of FCV in mechanically ventilated patients undergoing ear, nose and throat surgery and evaluate its potential for future use. DESIGN: An observational study. SETTING: Two German academic medical centres from 24 November 2017 to 09 January 2018. PATIENTS: Consecutive patients (≥ 18 years) scheduled for elective ear, nose and throat surgery. Exclusion criteria were planned laser surgery, intended fibreoptic awake intubation, emergency procedures, increased risk of aspiration, American Society of Anesthesiologists (ASA) physical status more than III and chronic obstructive pulmonary disease classified as GOLD stage more than II. INTERVENTION: Peri-operative use of FCV provided by a new type of ventilator (Evone) via a narrow-bore endotracheal tube (Tritube). MAIN OUTCOME MEASURES: Minute volume, respiratory rate, intratidal tracheal pressure amplitude (Δp) and end-tidal CO2 (PetCO2) were recorded every 5 min. All adverse events were noted. Data are presented as median [IQR]. RESULTS: Sixteen patients provided 15 evaluable data sets. A minute volume of 5.0 [4.4 to 6.4] l min and a respiratory rate of 9 [8 to 11] min generated a PetCO2 of 4.9 [4.8 to 5.0] kPa. Δp was 10 [9 to 12] cmH2O. Five adverse events were recorded: a tube obstruction due to airway secretions and four tube dislocations (two attributed to coughing, two not study-related). CONCLUSION: FCV achieves adequate PetCO2 levels with minute volume and Δp in the normal range. Tritube's high flow resistance may increase the likelihood of tube dislocations if the patient coughs. Although further evaluation is necessary, FCV provides a new option for short-term mechanical ventilation. The successful operation of FCV with narrow-bore tubes contributes to the armamentarium for airway management. TRIAL REGISTRATION: DRKS00013312.

来源:Eur J Anaesthesiol,查看原文。版权归原作者所有。

引用

  1. Schmidt J, Günther F, Weber J, et al. Flow-controlled ventilation during ear, nose and throat surgery: A prospective observational study. Eur J Anaesthesiol. 2019. PMID: 30730422. doi:10.1097/EJA.0000000000000967

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。